Exogenous thioredoxin reduces inflammation in autoimmune myocarditis.
Lowenstein
Charles J
CJ
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000276:immunology; D016166:Free Radical Scavengers / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009205:Myocarditis / Q000188:drug therapy* / Q000276:immunology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D017382:Reactive Oxygen Species; D015398:Signal Transduction / Q000187:drug effects; D013879:Thioredoxins / Q000494:pharmacology / Q000627:therapeutic use*
D000975:Antioxidants; D016166:Free Radical Scavengers; D017382:Reactive Oxygen Species; D013879:Thioredoxins